SCHEMBL30148522

SCHEMBL30148522

COc1ccc(OC)c(C2(O)CN(C(=O)OC(C)(C)C)C2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STS P08842 2/20 0.50
MET P08581 1/20 0.47
AXL P30530 1/20 0.47
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
ALDH1A1 P00352 1/20 0.44
PDE4B Q07343 5/20 0.42
GPR119 Q8TDV5 1/20 0.42
ROCK2 O75116 1/20 0.40
EPHX2 P34913 1/20 0.40
HTT P42858 1/20 0.40
CTSD P07339 1/20 0.39
CTSE P14091 1/20 0.39
BACE1 P56817 1/20 0.39
PDE4A P27815 1/20 0.39
PDE4C Q08493 1/20 0.39
PDE4D Q08499 1/20 0.39
SLC2A1 P11166 1/20 0.39
ABCB1 P08183 1/20 0.38
ESR2 Q92731 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30148531 1.00 STS (0.50) STSMETAXLMEN1KMT2A
SCHEMBL30148536 0.85 SLC2A1 (0.47) STSMETAXLSLC2A1
SCHEMBL30148507 0.85 YAP1 (0.45) METAXLPDE4BSLC2A1
SCHEMBL19202540 0.84 ALDH1A1 (0.43) STSMETAXLMEN1KMT2A
SCHEMBL17200972 0.83 SIGMAR1 (0.47) METAXLKMT2AALDH1A1PDE4B
SCHEMBL16874872 0.80 ALDH1A1 (0.51) STSALDH1A1GPR119HTTCTSD
SCHEMBL30148495 0.80 MET (0.43) STSMETAXLMEN1KMT2A
SCHEMBL30148494 0.80 CYP2C19 (0.41) MEN1KMT2AALDH1A1PDE4BHTT
SCHEMBL31084094 0.79 ALDH1A1 (0.52) MEN1KMT2AALDH1A1ROCK2
SCHEMBL29853675 0.78 CYP3A4 (0.40) STSMETAXLMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022221774-A1 ARYL-RING-SUBSTITUTED 3-PHENYLAZETIDINES AND THEIR USE IN METHODS FOR TREATING 5-HT2 RESPONSIVE CONDITIONS ELEUSIS THERAPEUTICS US, INC. (US) 2022-10-20 WO disclosed